경요도전립선적출술 및 절제술에 대한 예방적 항생제 사용: 1일 요법과 2일 이상 요법의 비교
Antimicrobial Prophylaxis in Transurethral Enucleation and Resection of the Prostate: A Comparison of 1-Day Treatment and More than 2-Day Treatment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the efficacy of 1-day treatment of antimicrobial prophylaxis by analysis of the incidence and risk factors for postoperative infectious complications such as bacteriuria and urinary tract infection in the transurethral enucleation and resection of the prostate (TUERP).Materials and Methods: A retrospective review of 78 patients who underwent TUERP was performed. Of 78 patients, 32 patients received antibiotics less than 1 day (group A). The other 46 patients received antibiotics for more than 2 days (group B). All patients had urinalysis and urine culture preoperatively, on the day of removal, at 1-2 weeks and 3-4 weeks after discharge. The incidence and the risk factors for postoperative infectious complication were investigated. Results: The incidence of infectious complications after TUERP was not statistically significant between group A and group B (18.8% vs. 15.2%, p=0.680). Multivariate analysis documented only two independent risk factors of postoperative infectious complications: preoperative catheterization (OR, 4.189; 95% CI, 1.071-16.382; p=0.040) and diabetes mellitus (DM) (OR, 5.589; 95% CI, 1.469-21.256; p=0.012). Comparative analysis performed in subgroups with two risk factors also showed no difference in the incidence of infectious complication regardless of antibiotic duration.Conclusions: No significant difference in the incidence of postoperative infectious complications was observed between two groups. Therefore, it seems reasonable to prescribe prophylactic antibiotics less than 1 day for reducing postoperative infectious complications after TUERP. Preoperative urethral catheterization and DM were identified as significant risk factors for postoperative infectious complications and preventive management directed against the risk factors preoperatively is recommended.
Abstract
Purpose: To evaluate the efficacy of 1-day treatment of antimicrobial prophylaxis by analysis of the incidence and risk factors for postoperative infectious complications such as bacteriuria and urinary tract infection in the transurethral enucleation and resection of the prostate (TUERP).Materials and Methods: A retrospective review of 78 patients who underwent TUERP was performed. Of 78 patients, 32 patients received antibiotics less than 1 day (group A). The other 46 patients received antibiotics for more than 2 days (group B). All patients had urinalysis and urine culture preoperatively, on the day of removal, at 1-2 weeks and 3-4 weeks after discharge. The incidence and the risk factors for postoperative infectious complication were investigated. Results: The incidence of infectious complications after TUERP was not statistically significant between group A and group B (18.8% vs. 15.2%, p=0.680). Multivariate analysis documented only two independent risk factors of postoperative infectious complications: preoperative catheterization (OR, 4.189; 95% CI, 1.071-16.382; p=0.040) and diabetes mellitus (DM) (OR, 5.589; 95% CI, 1.469-21.256; p=0.012). Comparative analysis performed in subgroups with two risk factors also showed no difference in the incidence of infectious complication regardless of antibiotic duration.Conclusions: No significant difference in the incidence of postoperative infectious complications was observed between two groups. Therefore, it seems reasonable to prescribe prophylactic antibiotics less than 1 day for reducing postoperative infectious complications after TUERP. Preoperative urethral catheterization and DM were identified as significant risk factors for postoperative infectious complications and preventive management directed against the risk factors preoperatively is recommended.
참고문헌 (28)
- Alsaywid BS, "Antibiotic prophylaxis for transurethral urological surgeries : Systematic review", Urol Ann, 5, pp.61~74 (2013)
- Berry A, "Prophylactic antibiotic use in transurethral prostatic resection : a meta-analysis", J Urol, 167, pp.571~577 (2002)
- Qiang W, "Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000bacteria per ml: a systematic review", J Urol, 173, pp.1175~1181 (2005)
- Kim CS, "Antimicrobial prophylaxis for urologic surgery", Korean J Urogenit Tract Infect Inflamm, 4, pp.20~36 (2009)
- 황의창, "술 전 무균뇨 환자에서 경요도전립선 수술 후 감염합병증의 위험인자", Urogenital Tract Infection, 8(1), pp.27~31 (2013), 대한요로생식기감염학회
- 김대현, "The Real Practice of Antibiotic Prophylaxis for Prostate Biopsy in Korea Where the Prevalence of Quinolone-Resistant Escherichia coli Is High", Investigative and Clinical Urology, 55(9), pp.593~598 (2014), 대한비뇨기과학회
- 정승일, "전립선수술에 대한 예방적 항생제요법", Urogenital Tract Infection, 9(1), pp.14~20 (2014), 대한요로생식기감염학회
- Bootsma AM, "Antibiotic prophylaxis in urologic procedures : a systematic review", Eur Urol, 54, pp.1270~1286 (2008)
- Mossanen M, "Overuse of antimicrobial prophylaxis in community practice urology", J Urol (2014)
- Cek M, "Antibiotic prophylaxis in urology departments, 2005-2010", Eur Urol, 63, pp.386~394 (2013)
- Calvert JK, "Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery", J Urol, 192, pp.425~429 (2014)
- Antimicrobial prophylaxis for surgery: presentation to Health-Care Institution, "Health Insurance Review & Assessment Service", Health Insurance Review & Assessment Service, ~ (2013)
- Zhao Z, "A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia : three-year follow-up results", Eur Urol, 58, pp.752~758 (2010)
- Grabe M, "Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures", World J Urol, 30, pp.39~50 (2012)
- Wagenlehner FM, "Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500mg levofloxacin versus 1920 mg trimethoprim", sulfamethoxazole versus a control group in patients undergoing TUR of the prostate, 2005, pp.47, 549~556
- Girou E, "The postoperative bacteriuria score: a new way to predict nosocomial infection after prostate surgery. Infect Control Hosp Epidemiol", Infect Control Hosp Epidemiol, 27, pp.847~854 (2006)
- Colau A, "Incidence and risk factors of bacteriuria after transurethral resection of the prostate", Eur Urol, 39, pp.272~276 (2001)
- Huang X, "Bacteriuria after bipolar transurethral resection of the prostate : risk factors and correlation with leukocyturia", Urology, 77, pp.1183~1187 (2011)
- El Basri A, "Clinical significance of routine urinary bacterial culture after transurethral surgery : results of a prospective multicenter study", Urology, 79, pp.564~569 (2012)
- Wolf JS Jr, "Best practice policy statement on urologic surgery antimicrobial prophylaxis", J Urol, 179, pp.1379~1390 (2008)
- Grabe M, "Guidelines on urological infections", EAU Guidelines Office, 70~92 (2014)
- Matsumoto T, "Japanese guidelines for prevention of perioperative infections in urological field", Int J Urol, 14, pp.890~909 (2007)
- "Guideline for prevention of catheter-associated urinary tract infections 2009" (2009)[URL]
- Wald HL, "Indwelling urinary catheter use in the postoperative period : analysis of the national surgical infection prevention project data", Arch Surg, 143, pp.551~557 (2008)
- Chen JS, "Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study", BJU Int, 110, pp.896~901 (2012)
- Geerlings SE, "Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment", Int J Antimicrob Agents, 31(Suppl 1), pp.S54~S57 (2008)
- Ambiru S, "Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan", J Hosp Infect, 68, pp.230~233 (2008)
- Vilar-Compte D, "Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy", Am J Infect Control, 36, pp.192~198 (2008)